Citigroup analyst issues BUY recommendation for LOW on August 20, 2026 09:39AM ET. The previous analyst recommendation was Buy.LOW was trading at $220.71 at issue of the analyst recommendation.The overall...
Barclays analyst issues UNDERWEIGHT recommendation for TGT on August 19, 2026 04:45PM ET. The previous analyst recommendation was Underweight.TGT was trading at $161.3 at issue of the analyst recommendation.The overall...
Oppenheimer analyst issues CAUTIOUS recommendation for WMT on August 19, 2026 02:23PM ET. The previous analyst recommendation was Perform.WMT was trading at $116.6572 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for KMB on August 19, 2026 01:07PM ET. The previous analyst recommendation was Overweight.KMB was trading at $109.48 at issue of the analyst recommendation.The...
Guggenheim analyst issues BUY recommendation for WMT on August 17, 2026 10:56AM ET. The previous analyst recommendation was Buy.WMT was trading at $115.27 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues OVERWEIGHT recommendation for ABBV on August 17, 2026 10:50AM ET. The previous analyst recommendation was Overweight.ABBV was trading at $249.45 at issue of the analyst recommendation.The...
Citigroup analyst issues MARKET OUTPERFORM recommendation for TGT on August 17, 2026 08:20AM ET. The previous analyst recommendation was Market Outperform.TGT was trading at $154.48 at issue of the analyst...
Telsey Advisory analyst issues OUTPERFORM recommendation for TGT on August 14, 2026 02:14PM ET. The previous analyst recommendation was Outperform.TGT was trading at $154.84 at issue of the analyst recommendation.The...
Bernstein analyst issues OUTPERFORM recommendation for PH on August 14, 2026 11:59AM ET. The previous analyst recommendation was Outperform.PH was trading at $1058.87 at issue of the analyst recommendation.The overall...
Bernstein analyst issues OUTPERFORM recommendation for EMR on August 14, 2026 11:57AM ET. The previous analyst recommendation was Outperform.EMR was trading at $164.19 at issue of the analyst recommendation.The overall...
